Background Cocaine use has been associated with cardiomyopathy and ischemic coronary syndromes. However, the pathophysiological mechanisms responsible for these syndromes are not clear and have been suggested to involve direct effects of cocaine on myocyte contractility and coronary resistance as well as indirect effects via altered autonomic tone, secondary mediators, and myocardial metabolism. We sought to distinguish direct from indirect effects of cocaine on ventricular function and coronary resistance by comparison of the administration of intracoronary cocaine (0.12 to 0.36 mg/min constant infusion) with intravenous cocaine (5 mg/kg bolus infusion) in an in vivo anesthetized pig preparation.
Background Cocaine use has been associated with cardiomyopathy and ischemic coronary syndromes. However, the pathophysiological mechanisms responsible for these syndromes are not clear and have been suggested to involve direct effects of cocaine on myocyte contractility and coronary resistance as well as indirect effects via altered autonomic tone, secondary mediators, and myocardial metabolism. We sought to distinguish direct from indirect effects of cocaine on ventricular function and coronary resistance by comparison of the administration of intracoronary cocaine (0.12 to 0.36 mg/min constant infusion) with intravenous cocaine (5 mg/kg bolus infusion) in an in vivo anesthetized pig preparation.
Methods and Results To control for changes in coronary resistance secondary to autoregulation and myocardial metabolism, the left anterior descending coronary artery was perfused at constant coronary pressure and the interventricular vein was cannulated for coronary venous oxygen saturation measurement. Coronary blood flow, regional percent segment shortening, myocardial oxygen consumption, and serum cocaine concentrations were measured. Intracoronary cocaine produced a dose-dependent decrease in percent segment shortening in the absence of significant changes in coronary flow or systemic hemodynamics. In contrast, intravenous cocaine had mild biphasic effects on coronary resistance with an initial brief vasodilation (30.0±5% increase in flow from control) followed by more prolonged vasoconstriction (17.0±3.3% decrease in flow from control), which were independent of autoregulation or myocardial metabolism. In addition, intravenous cocaine caused an early 48% decrease in percent segment shortening, at which time the measured cocaine concentration was 20.1 ,g/mL blood. This was comparable to the intracoronary cocaine concentration of 17.1 ,g/mL blood, which produced a similar 48% decrease in percent segment shortening.
Conclusions We conclude that the effects of acute cocaine exposure on ventricular function are predominantly direct but of brief duration and therefore probably not clinically relevant. The effects of cocaine on coronary tone are predominantly indirect and biphasic, with early vasodilation followed by mild and more prolonged vasoconstriction. In the absence of coronary stenosis or ventricular hypertrophy, this small amount of vasoconstriction is unlikely to cause ischemia. (Circulation. 1994; 89:1819 -1828 Key Words * inotropic agents * microcirculation . perfusion * vasoconstriction * pressure I ncreased cocaine use in the United States has resulted in continued reports of cocaine-related cardiomyopathy and ischemic coronary syndromes.1,2 Cocaine cardiomyopathy has been described in many case reports, yet the pathogenesis of this syndrome is largely unexplained.3,4 Cocaine use has been associated with premature coronary stenosis and ventricular hypertrophy, but these have not been prerequisite for myocardial infarction. [5] [6] [7] In more than 100 reported cases of cocaine-related myocardial infarction, only 2 cases of focal coronary spasm have been observed at coronary catheterization.5'8 Cocaine-related myocardial infarction without fixed coronary artery disease has also been reported in the setting of rhinolaryngolic surgery. 9 Controlled conscious human studies demonstrate only modest epicardial coronary constriction without evidence of ischemia. 10 Thus, the clinical evidence for a relation between the ischemic syndromes of cocaine and coronary constriction is weak, and the pathophysiology of the inotropic and coronary effects of cocaine remains controversial. It has long been known that cocaine has systemic sympathomimetic effects caused by blocked reuptake of norepinephrine at postsynaptic sympathetic nerve terminals.2 However, in addition to these indirect adrenergic effects, contradictory evidence exists as to whether cocaine also affects the coronary microcirculation and myocardium directly. Cocaine where A is arterial. V is venous, and diff is difference. Oxygen supply (mL 0* min-m . 100 g-') was calculated by the formula (A On content)xCBF/g. Regional segment shortening was measured by use of pairs of lensed ultrasonic dimension crystals (2 mm in diameter) placed in both the cannulated LAD (treatment) region and the left circumflex artery (LCx) (control) region at a depth of 6 to 8 mm. Percent segment shortening (%SS) was calculated with the formula (EDL-ESL)x100/EDL, where EDL is end-diastolic length and ESL is end-systolic length. Samples for plasma cocaine concentration determination were obtained from the perfusion circuit at appropriate times into tubes containing sodium fluoride (7.5 mg). These samples were centrifuged to separate out plasma and frozen at < -10C until assayed by gas chromatography/mass spectroscopy (GC/MS) (see below). At the termination of each experiment, 2 mL monastral blue dye (Sigma Chemical Co, St Louis, Mo) was rapidly injected into the perfusion line. The weight of the dyed portion was used to estimate the mass of the LAD-perfused myocardium for normalization of measured CBF per gram of myocardium
Cocaine Preparation
Cocaine HCl (Sigma) was dissolved at room temperature to desired concentrations (IV experiments, 5 mg* kg`. 5 mL-1 and IC experiments, 0.12 to 0.36 mg!mL). Cocaine administered via the IC route was further filtered (0.4 uim) before infusion. Cocaine solutions were prepared just before use and shielded from light to prevent decay.
Cocaine Measurement
Cocaine concentrations were measured by GC/MS. The three-step liquid/liquid extraction of plasma samples used provided a clean extract for analysis by MS.22 After the deuterated internal standard (cocaine-d3, Sigma) was added, the pH of a 1-mL plasma sample was adjusted to approximately 9 by addition of 1 mL of saturated sodium borate. Samples were extracted with 3 mL of organic solvent (toluene/ hexanelisoamyl alcohol 78/20/2 vollvol) by gentle shaking for 5 minutes. After centrifugation, the organic layer was pipetted off into a clean test tube and back-extracted into 0.5N sulfuric acid by vigorous vortexing. The organic layer was discarded, and the acid layer was made basic by the addition of sodium bicarbonate/potassium carbonate (3/2 wt/wt) and extracted with 150 ,L of the organic solvent.
One microliter of the plasma extract was injected into the GC/MS by use of a splitless injection. The mass spectrometer is operated in the electron impact ionization mode. Molecular ion quantification was based on area ratios of the cocaine relative to that of the internal standard. The linear range of the method is 0.200 to 6.00 ,ug/mL. After preliminary experiments demonstrated that the first time points would contain concentrations of cocaine greater than the linear range, these samples were diluted with water before extraction. The precision of the assay was determined by injecting a control plasma sample on five different days for an N=12. The mean concentratiori wa, Zimring et al Intracoronary vs Intravenous Effects of Cocaine 1821 8.83 ±0.38 ,g/mL, showing that the day-to-day precision had a coefficient of variation of <5%. The percent error of the method from the range of 6.0 to 0.2 ,g/mL was <6% (N=6 at each concentration).
Cocaine serum-to-blood conversion factor was obtained by spiking pig whole blood with cocaine, separating out the plasma, and assaying the plasma by GC/MS. Three different concentrations (from 5 to 15 ,g/mL) were analyzed in duplicate, and the ratio of cocaine in plasma to whole blood was 0.80±0.06.
Statistical Analysis
A paired t test with Bonferroni's correction was used to test for statistical significance between the control value and the response after each intervention in all experimental groups and is indicated in the figures. All confidence intervals represent SEM.
Experimental Design
Two groups of experiments were performed. The goal of the first group was to distinguish direct from indirect effects of cocaine by comparison of IC and IV cocaine administration. Five animals were instrumented as above, and each was treated with three or four consecutive doses of IC cocaine followed by one dose of IV cocaine. Thus, group 1 had two subgroups, which will be referred to as "Group 1: IC Cocaine" and "Group 1: IV Cocaine" in the remainder of this article. The goal of the second group was to determine the relation between cocaine-induced changes in myocardial metabolism and changes in CBF. Ten animals were instrumented as above and treated with only IV cocaine. This second group will be referred to as "Group 2: Myocardial Metabolism."
Group 1: IC Cocaine
After control data were collected, IC cocaine was administered through the LAD (treatment) perfusion circuit at doses of 0.12 to 0.36 mg/mL with a Harvard infusion pump at rates of 0.5 to 1.6 mL/min for 6 minutes, which yielded cocaine blood concentrations of 2 to 20 ,g/mL in the various animals based on CBF. This dose range was based on pilot studies (n=2) demonstrating no significant response to concentrations <2 ,ug/mL and the upper values of blood cocaine concentrations (>25 ,ug/mL) associated with cocaine-related death in humans. 23 Variables recorded were heart rate, LV end-systolic and end-diastolic (LVEDP) pressures, dP/dt, coronary pressure, mean and raw CBF, and segment shortening in the LAD (treatment) and LCx (control) coronary beds. The variables were recorded and analyzed with analog records at 0-, 3-, 6-, 10-, 16-, and 24-minute time points. Baseline steady-state flow and function were achieved before repeat IC or IV cocaine was administered. After completion of the highest dose of IC cocaine, coronary artery serum cocaine concentration was measured to assess for the extent of recirculation of drug and was found to be <0.250 ,ug/mL.
Control IC infusions of vehicle (normal saline) performed at 2 mL/min excluded a possible effect of the infusion rate on CBF measurements. Tachyphylactic and additive effects were excluded by three consecutive 10-minute infusions of IC cocaine (0.36 mg/min) in a pilot study in which no additional effects were observed. Six-minute infusions were sufficient for steady state.
Group 1: IV Cocaine
After the last dose of IC cocaine, the animal was allowed to return to baseline steady state for at least 30 minutes. A bolus injection of IV cocaine (5 mg/kg) was then given via the femoral vein. Variables were recorded as above and coronary artery serum cocaine levels determined at 0-, 2-, 4-, 6-, 10-, 16 -, and 30-minute time points.
Group 2: Myocardial Metabolism
After instrumentation and baseline data were recorded, a bolus injection of IV cocaine (5 mg/kg) via the femoral vein was given. Segment shortening in the LCx coronary bed was not measured. Measurements of serum cocaine levels were performed in five of the animals from group 2, with additional samples taken at 30, 60, and 90 minutes to determine the elimination rate of cocaine during this period. All other variables were recorded as above at 0-, 2-, 4-, 6-, 10-, 16-, and 30-minute time points with the additional simultaneous collection of coronary venous and coronary arterial blood for myocardial oxygen consumption analysis at all time points.
Since the IV experimental runs from group 1 (n=5) and group 2 (n= 10) were identical with regard to dose, the data on CBF, %SS, and hemodynamics were combined and presented as a single data set (n= 15).
Results

IC Cocaine
Average values for measured variables in five pigs that were given IC cocaine for 6 minutes at varying concentrations are presented in Table 1 and Figs 1 and 2. Three whole-blood IC cocaine concentrations were calculated on the basis of the infusion concentrations and CBF of the individual animals: low, 4.6+0. 4 ,ug/mL; mid, 9.8±0.4 ,g/mL; and high, 15 .1+0.8 ,tg/mL ( Fig   1B) . IC cocaine administration was associated with minor (<10% baseline) changes in both heart rate and systolic blood pressure at all doses (Table 1) .
IC cocaine caused a significant decrease in LAD %SS at 6 minutes, which was dose dependent in the five animals (Figs 1 and 2B ). All %SS LAD decreases were significantly different from %SS LCx (control) at the 6-minute equilibrium time point (Fig 2A) . The onset to peak effect on decreased %SS LAD occurred within 6 minutes at all three cocaine concentrations. The recovery from maximum decrease %SS LAD occurred within 10 minutes of stopping the cocaine infusion at all concentrations (Fig 2A) . These changes occurred in the absence of decreases in CBF at constant perfusion pressure (Fig 1) or changes in LCx %SS (Fig 2A) during the cocaine infusion. In contrast, CBF at the steadystate 6-minute time was not significantly different from baseline at all IC cocaine concentrations tested ( Fig  1A) . The only statistically significant change in CBF occurred as a late response 4 minutes after the IC cocaine infusion was completed during the mid and high IC cocaine concentrations (Fig 2B) . The decreases in CBF were 9.2±2.4% and 14.4±3.2%, respectively, for mid and high concentrations and returned to baseline control CBF within the subsequent 6 minutes.
IV Cocaine
Mean values for 15 pigs (5 from group 1, 10 from group 2) given IV cocaine 5 mg/kg are presented in Figs 3 through 6. Measured cocaine concentrations during the IV cocaine administration are presented in Fig 3. IV cocaine produced a peak increase to 16.1±2. 4 ,ng/mL plasma (20.1 ,ug/mL whole blood) at 2 minutes, followed by a rapid decrease due to distribution within 6 minutes to 2.9 ,ug/mL plasma (3.6 pig/mL whole blood).
Between 30 and 90 minutes, cocaine was being eliminated from the plasma with a half-life of 50.0±1.3 minutes (n=5). IV cocaine produced changes in systemic hemodynamics compared with IC cocaine (Tables 1 and 2 , Fig  4) , resulting in an initial significant decrease in ratepressure product from control (Fig 4) . The CBF response to IV cocaine was biphasic, with an initial brief significant 30.0+5.3% increase followed by a significant 17.0±3.3% maximum decrease, which was more sustained (Fig 5) and still significant at 30 minutes after injection. The %SS LAD was observed to decrease significantly (48%) from control by 4 minutes and return to control by 30 minutes (Fig 5) . This was comparable to the IC cocaine concentration of 17.1 ,g/mL blood, which produced a similar 48% decrease in %SS ( Fig  1A) . Regarding ventricular diastolic function, the LVEDP was observed to increase significantly by 4 minutes ( Oxygen content, extraction, and consumption data in 10 pigs given only IV cocaine 5 mg/kg are shown in Figs 5 through 8. An early significant increase in coronary venous oxygen content was observed, followed by a later significant decrease in coronary venous oxygen content at 10 minutes (Fig 6A) . In contrast, the coronary artery oxygen contents did not change significantly from control. The coronary artery to coronary vein oxygen content difference was significantly decreased at 2 minutes and significantly increased at 10 minutes (Fig 6B) . Analysis of oxygen consumption and supply relative to their control values demonstrated changes from control at the 2-, 4-, 6-, and 10-minute time points, all of which were significant (*P<.05, Fig 7) .
A "supply/demand" plot of coronary vasomotion was performed to analyze the effects of cocaine on CBF.24 In this plot, which is a modification of the plot of CBF versus myocardial oxygen consumption of Ekhenhoff et al,25 oxygen supply is plotted against oxygen consumption, resulting in a series of "isoextraction" lines representing changes in oxygen supply and myocardial oxygen consumption. This allowed us to interpret changes in CBF relative to the myocardial metabolism at various times. Vectors to the left of an initial isoextraction line represent relative coronary vasodilation, and vectors to the right indicate relative coronary vasoconstriction. The early vasodilatory and later vasoconstrictive effects of cocaine are demonstrated in Fig 8A. IV cocaine 5 mg/kg caused vasodilation at the early 2-minute time, as depicted by the upward vector perpendicular to the isoextraction line. This represented an increase in CBF despite a concurrent decreased oxygen consumption stimulus for decreased CBF. The 4-minute vector is nearly parallel to the original isoextraction line and therefore represents a transition between vasodilation and vasoconstriction in which the change in CBF can be accounted for by changes in myocardial oxygen consumption. At 6 minutes, the vertical down vector represents pure coronary vasoconstriction independent of metabolic effects. The 10-minute vector is perpendicular and downward to the isoextraction line and thus represents vasoconstriction. Here CBF decreased de- 14 16 18 Cocaine ,ug (Fig 1A and 1B) . Likewise, in the IV cocaine group, CBF was increasing simultaneously with the significant decrease in %SS (Fig 5) . The majority of the effect on function appeared not to be secondary to indirect hemodynamic effects. Evidence for this was The mechanism responsible for the negative inotropic effect of cocaine is unclear from the present study but has been postulated to be secondary to membrane anesthetic effects.2 Whatever the cause, it remains unclear whether the negative inotropic effect is clinically significant. The rapid recovery response after IC cocaine (Fig 2B) In contrast to the effects of cocaine on LV function, there was no observed direct effect of IC cocaine on CBF at constant coronary perfusion pressure during any of the tested infusion concentrations. A mild late decrease in CBF of 15.4+3.2% occurred well after the IC cocaine infusion was stopped. The mechanism of this response is not clear. It is possible that this represented a delayed response to cocaine not apparent in the 6-minute infusion period. However, in our pilot studies, 6 minutes was sufficient for steady state, and an increase to 10 minutes was without additional effect. It is also conceivable that the decrease in CBF was a response to very low levels of cocaine due to recirculation in the IC experiments and redistribution in the IV experiments. This dose-dependent effect has been reported to be a characteristic of some local anesthetics.27 Evidence arguing against this possibility is shown in Fig lA, without effect on flow. Another possible explanation for the late decrease in CBF could be a decrease in myocardial oxygen consumption secondary to decreased contractility. Unfortunately, because pilot studies had no late decreased flow, oxygen consumption was not measured in this experimental group. Arguing against this possible explanation is the observation that %SS had nearly returned to baseline control levels by the time of late decreased CBF. One last possibility would be the presence of cocaine metabolites. Benzoylecgonine and ethyl methyl ecgonine have been shown to appear 30 to 60 minutes after IV cocaine infusion. 28 However, because of the low dose of IC cocaine and time course of late decreased CBF, this seems unlikely. We are thus unsure as to the explanation for the observed late decreased CBF at the present time; however, its magnitude was small, and it was unlikely to represent the mechanism of clinical cocainerelated ischemia. The observation of a mild late coronary constriction observed during IV cocaine is in accord with several prior studies. Hayes et al19 measured CBF with microspheres 30 minutes after 1 to 9 mg/kg IV cocaine exposure in an angiographic study on anesthetized dogs. They reported a decrease in CBF at this latter time point of 23% after IV cocaine 10 mg/kg. A recent perfused septum preparation by Morcos et tion. Alternatively, this observation may be due to a dissociation of the normal link between myocardial oxygen consumption and coronary tone. Cocaine may impair either the signal or reception of the signal for myocardial oxygen consumption-induced vasodilation and thereby result in a "coronary paralysis." Evidence for this has been seen previously by Fraker et al,1' who observed an unexplained dissociation in rate-pressure product and CBF in a dog preparation given IV cocaine. Our data support this concept at both the early vasodilation and later vasoconstriction time periods, when flow changed despite metabolic stimuli. This later vasoconstriction could therefore represent a period of myocardial vulnerability to ischemia caused by an inability of the coronary microvasculature to react to increased myocardial consumption. Further experimentation will be necessary to distinguish these possible mechanisms.
Our findings of an early coronary vasodilation response to IV cocaine are in agreement with a prior in vivo study by Friedrichs et a120 that also controlled for coronary perfusion pressure. This study exposed anesthetized beagles to IV cocaine (0.4 to 10 mg/kg) while maintaining constant CBF. Measured coronary pressure was found to decrease 65% from control after the high dose of IV cocaine. When CBF was allowed to vary, it increased 175% from control 60 seconds after administration. It was concluded that cocaine caused dose-dependent coronary vasodilation. Consideration of later time course effects was not performed in their study. As an anecdote, it was mentioned that a single dog was given an unspecified dose of IC cocaine, with equivalent coronary dilation observed.
The early vasodilation we observed is in disagreement with conclusions from a recent study by Shannon et al. 16 They measured changes in myocardial oxygen consumption and CBF in a conscious dog preparation subjected to 1 mg/kg IV cocaine. They observed an early increase in CBF at 2 minutes, but they concluded that coronary constriction was present because of an increased difference in measured coronary sinus and arterial oxygen contents due entirely to an unexplained increase in arterial oxygen content. Given the concomitant increased systolic blood pressure response to cocaine, it was concluded that the early increase in CBF represented coronary vasoconstriction independent of myocardial oxygen consumption. However, when these data are analyzed by the technique of Mohrmon et al24 described above, the vector describing the effects of cocaine on supply versus demand is nearly parallel to the initial isoextraction line (Fig 8B) . This suggests that the observed changes in CBF at the time oxygen saturation was measured were largely explained by an increase in myocardial oxygen consumption. Interestingly, only with norepinephrine given IV alone (Fig 8B) did a vector significantly cross an isoextraction line, indicating a partial primary coronary constrictive effect. Thus, a primary change in coronary tone independent of myocardial oxygen consumption was not apparent at this time of early increased CBF when analyzed in this fashion. A similar analysis of the data from our preparation over a 30-minute time course (Fig 8A) 10 minutes) was a true vasoconstriction independent of metabolism apparent (Fig 8A) .
Previously reported variability in the coronary vascular resistance effects of IV cocaine has been ascribed to differences in preparations with regard to conscious versus anesthetized, type of anesthetic, and species studied.2 An additional source of variability suggested by our results is failure to consider effects of metabolic regulation on CBF. The biphasic nature of this response adds yet another element of variability to coronary resistance measurement. Thus, both metabolic influences and the timing of sample measurement during the first 4 minutes after cocaine administration are critical to interpretation of the effects of cocaine on coronary tone.
There are several possible explanations for the biphasic CBF response observed with IV but not IC cocaine. First, in vitro studies have reported that adrenergic blockade can influence the effects of cocaine on coronary vascular tone. 13 Increased adrenergic activity has therefore been proposed as an explanation for the effect of cocaine on coronary tone. Also, in vitro evidence suggests that a direct vasodilatory effect of cocaine is apparent at 10-4 mol/L (30 ,ug/mL) concentrations. It is therefore possible that the biphasic coronary resistance response to IV cocaine can be explained by competing influences of high-dose direct membrane anesthetic (vasodilation) and low-dose indirect sympathomimetic (vasoconstriction) effects of cocaine. Absence of effect with high doses of IC cocaine (20 ,ug/mL) in our study argues against this theory; however, it is feasible that cocaine levels during the initial distributive phase of our intravenous bolus injection were >20 1£g/mL. It However, in conscious preparations that measure oxygen consumption, the magnitude of coronary vasoconstriction independent of metabolism appears to be quite small early after IV cocaine (Fig 8B) . Thus, both conscious and anesthetized studies agree that coronary vascular resistance changes secondary to cocaine appear to be too mild to cause ischemia. It is possible that in the presence of minimal coronary atherosclerosis, which has been shown to alter coronary vasoconstrictive responses,33,34 the response to cocaine could be potentiated. Both myocardial hypertrophy and premature coronary atherosclerosis have been associated with chronic cocaine use and could, in addition to acute mild vasoconstriction, contribute to clinical ischemia.6'7 Limitations This preparation had both advantages and disadvantages. Its primary advantage was that it provided a highly controlled means of assessing the complex coronary vascular, inotropic, metabolic, and hemodynamic effects of acute cocaine administration. Also, use of the pig has the advantage of its having essentially no collateral coronary circulation, which may confound studies in dogs. The primary disadvantage of our preparation is that anesthesia was used, which probably blunted part of the indirect hemodynamic effect of IV cocaine. This may have resulted in higher doses of cocaine being required to produce the measured effects as previously described by Fraker et al. 11 To minimize the effects of anesthetic on the sympathetic nervous system, a-chloralose anesthesia was used. Although the doses of cocaine were higher than those in conscious studies, they appeared to be clinically relevant on the basis of our measured cocaine levels, which correlate with cocaine serum concentrations measured in autopsy studies taken well after the victim was exposed to cocaine.23 Also, cocaine is commonly used as a topical agent during human rhinolaryngolic surgery under anesthetized conditions at doses exceeding 400 mg.9 Last, the surgery that was required to instrument the animal required dissection of the proximal LAD, which could have impaired its sympathetic innervation. However, it is unlikely that this could have accounted for our results of a clear vasoconstriction when cocaine was given IV but not IC. Summary
The above results demonstrate that cocaine causes direct decreases in contractile function that are sustained for the duration of exposure but rapidly recover after cocaine is removed. This argues against the clinical significance of the observed negative inotropic effect. Conversely, over a wide range of doses, cocaine has minor direct effects on coronary vascular resistance. When it is given IV, the effects of cocaine on coronary tone are predominantly indirect and biphasic in nature, with early brief vasodilation followed by more sustained vasoconstriction independent of metabolic changes. The magnitude of this later effect is small and thus unlikely to be clinically significant in individuals without coronary disease or myocardial hypertrophy.
